Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02088541
Title Selinexor (KPT-330) in Older Patients With Relapsed AML
Acronym SOPRA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | ISR | GBR | FRA | ESP | DNK | DEU | CAN


No variant requirements are available.